Here are Case Studies using Healthentia as part of a Clinical Trial or as a Remote patient monitoring Solution

Study Description COMFORTAGE is a joint effort of medical experts, social scientists and humanists, technical experts, Digital Innovation Hubs (DIHs) and Living Labs (LLs) to establish a pan European framework for Community-based, Integrated and People-Centric prevention, monitoring and progression managing solutions for dementia and frailty. Through COMFORTAGE, care services providers will be empowered to create...
Study Description VirT2D is a co-sponsored Study with the University of Thessaly using Healthentia to offer personalized coaching to 30 patients with Type 2 Diabetes. The study consists of a 2-week assessment period followed by a 12 week intervention period with mandatory completion of questionnaires, weight and glucose measurement monitoring and two teleconsultations with a dietician. Study Details...
Study Description ONCODIR (Evidence-based Participatory Decision Making for Cancer Prevention through implementation) will identify risk factors associated with colorectal cancer (CRC) and will integrate multidisciplinary research methods and technologies (including health policy analytics, artificial intelligence, and decision support theories) to deliver evidence-based and personalized recommendations on colorectal cancer prevention. Study Details Type: HORIZON-RIA, HORIZON-MISS-2022-CANCER-01-01 Start:...
  Study Description HumAIne facilitates advanced and reliable collaboration of experts and AI towards hybrid decision making and support in a variety of industries. It delivers the HumAIne Operating System, built on four technological pillars: Active Learning (AL), Neuro-Symbolic Learning, Swarm Learning (SL), and eXplainable AI (XAI). The HumAine OS enables AI solution creators to...
Study Description The IBS study is a prospective, randomised, double-blind, placebo controlled, multicentre, parallel group, phase II study. The study will recruit 130 patients across 13 centres in Belgium and they will undergo 5 study visits, plus a follow-up phone call (if they agree to free-access to the product for 4 additional weeks) with a...